199 related articles for article (PubMed ID: 12439840)
21. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Woo KT; Lee GS; Lau YK; Chiang GS; Lim CH
Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
[TBL] [Abstract][Full Text] [Related]
22. [Nicardipine, alone or in combination with enalapril, in the therapy of arterial hypertension secondary to chronic nephropathy].
Pecci G; Feriozzi S; Morabito S; Mavrikakis G; Roscia E; Simonetti BM; Pierucci A
Clin Ter; 1989 Sep; 130(6):327-32. PubMed ID: 2572374
[TBL] [Abstract][Full Text] [Related]
23. IgA nephropathy (IgAN) presenting with the nephrotic syndrome.
Oviasu E
Trop Geogr Med; 1992 Oct; 44(4):365-8. PubMed ID: 1295149
[TBL] [Abstract][Full Text] [Related]
24. Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
Hotta O; Taguma Y; Kurosawa K; Sudo K; Suzuki K; Horigome I
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):967-73. PubMed ID: 8255008
[TBL] [Abstract][Full Text] [Related]
25. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
[TBL] [Abstract][Full Text] [Related]
26. Prognostic indicators and treatment of childhood IgA nephropathy.
Hogg RJ
Contrib Nephrol; 1995; 111():194-9; discussion 199-200. PubMed ID: 7758342
[No Abstract] [Full Text] [Related]
27. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Visciano B; Pani A; De Silvestri A; De Simone I; Del Vecchio L; Terraneo V; Furiani S; Santagostino G; Corghi E; Pozzi C
PLoS One; 2016; 11(7):e0158584. PubMed ID: 27416024
[TBL] [Abstract][Full Text] [Related]
28. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.
Glöckner WM; Sieberth HG; Wichmann HE; Backes E; Bambauer R; Boesken WH; Bohle A; Daul A; Graben N; Keller F
Clin Nephrol; 1988 Jan; 29(1):1-8. PubMed ID: 3289804
[TBL] [Abstract][Full Text] [Related]
29. Concomitant administration of isradipine and spirapril prevents reduction of renal function induced by acute administration of spirapril in patients with reduced renal function.
Wittenberg C; Erman A; Shohat J; Boner G
Blood Press Suppl; 1994; 1():48-9. PubMed ID: 8205299
[TBL] [Abstract][Full Text] [Related]
30. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial.
Bennett WM; Walker RG; Kincaid-Smith P
Clin Nephrol; 1989 Mar; 31(3):128-31. PubMed ID: 2539929
[TBL] [Abstract][Full Text] [Related]
31. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG; Yu SH; Owen JE; Kincaid-Smith P
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[TBL] [Abstract][Full Text] [Related]
32. Controlled trial of azathioprine and prednisone in chronic renal disease. Report by Medical Research Council Working Party.
Medical Research Council Working Party
Br Med J; 1971 May; 2(5756):239-41. PubMed ID: 4929367
[TBL] [Abstract][Full Text] [Related]
33. Comparison of alternate day steroids and daily steroids in renal transplant recipients.
Davisson NA; Westervelt FB; Bolton WK
Proc Clin Dial Transplant Forum; 1980; 10():150-4. PubMed ID: 7050977
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].
Hogg RJ; Wyatt RJ;
BMC Nephrol; 2004 Mar; 5():3. PubMed ID: 15043759
[TBL] [Abstract][Full Text] [Related]
35. [Current trends in the treatment of chronic glomerulonephritis].
Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
[TBL] [Abstract][Full Text] [Related]
36. [Conversion enzyme inhibitors in the antihypertensive treatment of patients with renal insufficiency].
Reisch C; Mann J; Ritz E
Dtsch Med Wochenschr; 1987 Aug; 112(33):1249-52. PubMed ID: 2886330
[TBL] [Abstract][Full Text] [Related]
37. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
Kobayashi Y; Fujii K; Hiki Y; Tateno S; Kurokawa A; Kamiyama M
Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
[TBL] [Abstract][Full Text] [Related]
38. Capillaritis in IgA nephropathy.
Ferrario F; Napodano P; Rastaldi MP; D'Amico G
Contrib Nephrol; 1995; 111():8-12. PubMed ID: 7758350
[No Abstract] [Full Text] [Related]
39. Renal function in IgA nephropathy with established renal failure.
Fellin G; Gentile MG; Duca G; D'Amico G
Nephrol Dial Transplant; 1988; 3(1):17-23. PubMed ID: 3132634
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin A nephropathy: fish oils and beyond.
Feehally J
Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):442-6. PubMed ID: 8937814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
